Table 1 |
|||||
|
Trend of liver function tests |
|||||
|
Blood test |
Day |
||||
|
|
|||||
|
Day 0 |
181 |
22 |
30 |
90 |
|
|
ALT (U/L)2 |
346 |
170 |
100 |
76 |
20 |
|
AST (U/L)2 |
158 |
100 |
96 |
58 |
14 |
|
Total bilirubin (mg/dL) |
6.28 |
14.7 |
10.6 |
6 |
0.2 |
|
Direct bilirubin (mg/dL) |
4.26 |
12.6 |
8.4 |
4.1 |
0.1 |
|
Alkaline phosphatase (U/L) |
1.09 |
428 |
340 |
298 |
146 |
|
GGT (U/L)2 |
250 |
170 |
140 |
98 |
12 |
|
|
|||||
|
1HCTZ therapy stopped. 2ALT = alanine amino-transferase; AST = aspartate amino-transferase; GGT = gamma glutammin transferase |
|||||
|
Taglietti et al. Journal of Medical Case Reports 2010 4:332 doi:10.1186/1752-1947-4-332 |
|||||
